Market Closed -
Nasdaq
21:00:00 01/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.8787
USD
|
-2.48%
|
|
+28.63%
|
-37.68%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
197.7
|
53.19
|
59.69
|
43.75
|
-
|
-
|
Enterprise Value (EV)
1 |
197.7
|
53.19
|
59.69
|
43.75
|
43.75
|
43.75
|
P/E ratio
|
-3.56
x
|
-0.88
x
|
-1.12
x
|
-0.88
x
|
-1.06
x
|
-1.67
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
395
x
|
141
x
|
24.6
x
|
7.63
x
|
2.65
x
|
0.97
x
|
EV / Revenue
|
395
x
|
141
x
|
24.6
x
|
7.63
x
|
2.65
x
|
0.97
x
|
EV / EBITDA
|
-7.21
x
|
-0.98
x
|
-1.3
x
|
-1.07
x
|
-1.21
x
|
-1.27
x
|
EV / FCF
|
-10.7
x
|
-1.74
x
|
-
|
-1.08
x
|
-1.45
x
|
-3.17
x
|
FCF Yield
|
-9.37%
|
-57.5%
|
-
|
-92.9%
|
-69.1%
|
-31.6%
|
Price to Book
|
3.43
x
|
2.39
x
|
-
|
-1.06
x
|
-0.59
x
|
-
|
Nbr of stocks (in thousands)
|
36,809
|
39,108
|
42,330
|
49,784
|
-
|
-
|
Reference price
2 |
5.370
|
1.360
|
1.410
|
0.8787
|
0.8787
|
0.8787
|
Announcement Date
|
28/03/22
|
14/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
0.5
|
0.377
|
2.428
|
5.733
|
16.48
|
45.15
|
EBITDA
1 |
-
|
-27.42
|
-54.24
|
-45.98
|
-40.85
|
-36.2
|
-34.47
|
EBIT
1 |
-
|
-27.42
|
-56.17
|
-48.48
|
-45.37
|
-40.92
|
-27.57
|
Operating Margin
|
-
|
-5,483.8%
|
-14,899.47%
|
-1,996.79%
|
-791.32%
|
-248.35%
|
-61.06%
|
Earnings before Tax (EBT)
1 |
-
|
-28.08
|
-56.17
|
-52.67
|
-46.68
|
-44.95
|
-42
|
Net income
1 |
-8.28
|
-28.08
|
-56.17
|
-52.67
|
-46.97
|
-42.59
|
-40.87
|
Net margin
|
-
|
-5,615.6%
|
-14,899.47%
|
-2,169.11%
|
-819.22%
|
-258.46%
|
-90.52%
|
EPS
2 |
-0.5882
|
-1.510
|
-1.550
|
-1.260
|
-0.9980
|
-0.8320
|
-0.5275
|
Free Cash Flow
1 |
-
|
-18.53
|
-30.59
|
-
|
-40.62
|
-30.22
|
-13.81
|
FCF margin
|
-
|
-3,706%
|
-8,114.85%
|
-
|
-708.55%
|
-183.41%
|
-30.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/09/21
|
28/03/22
|
14/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
0.2
|
0.3
|
0.189
|
-
|
0.076
|
0.112
|
0.446
|
0.159
|
0.783
|
1.04
|
1.046
|
1.292
|
1.556
|
1.868
|
1.633
|
EBITDA
1 |
-6.51
|
-11.24
|
-12.25
|
-13.92
|
-13.76
|
-14.31
|
-15.68
|
-10.66
|
-13.55
|
-10.82
|
-9.925
|
-10.35
|
-10.3
|
-10.28
|
-9.867
|
EBIT
1 |
-6.566
|
-11.24
|
-12.77
|
-14.62
|
-14.35
|
-14.93
|
-14.32
|
-11.58
|
-11.13
|
-11.45
|
-11.36
|
-11.29
|
-11.32
|
-11.4
|
-11.47
|
Operating Margin
|
-3,283%
|
-3,747%
|
-6,756.61%
|
-
|
-18,880.26%
|
-13,328.57%
|
-3,210.09%
|
-7,285.53%
|
-1,421.2%
|
-1,101.25%
|
-1,085.76%
|
-873.78%
|
-727.19%
|
-610.05%
|
-702.04%
|
Earnings before Tax (EBT)
1 |
-7.013
|
-11.31
|
-12.27
|
-14.62
|
-14.35
|
-14.93
|
-16.25
|
-11.38
|
-14.21
|
-10.83
|
-11.53
|
-11.64
|
-11.67
|
-11.81
|
-12.15
|
Net income
1 |
-6.957
|
-11.31
|
-12.27
|
-14.62
|
-14.35
|
-14.93
|
-16.25
|
-11.38
|
-14.21
|
-10.83
|
-11.73
|
-11.73
|
-11.72
|
-11.8
|
-12.3
|
Net margin
|
-3,478.5%
|
-3,768.67%
|
-6,492.06%
|
-
|
-18,880.26%
|
-13,328.57%
|
-3,642.83%
|
-7,157.86%
|
-1,814.56%
|
-1,041.35%
|
-1,120.81%
|
-907.31%
|
-752.89%
|
-631.46%
|
-753.06%
|
EPS
2 |
-0.4900
|
-0.3200
|
-0.3500
|
-0.4100
|
-0.3900
|
-0.4000
|
-0.4000
|
-0.2700
|
-0.3400
|
-0.2500
|
-0.2680
|
-0.2480
|
-0.2440
|
-0.2420
|
-0.2500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/11/21
|
28/03/22
|
11/05/22
|
15/08/22
|
14/11/22
|
14/03/23
|
15/05/23
|
14/08/23
|
13/11/23
|
25/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-18.5
|
-30.6
|
-
|
-40.6
|
-30.2
|
-13.8
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
1.570
|
0.5700
|
-
|
-0.8300
|
-1.490
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.86
|
0.91
|
-
|
1.41
|
2.37
|
4.07
|
Capex / Sales
|
-
|
172.4%
|
240.85%
|
-
|
24.68%
|
14.39%
|
9%
|
Announcement Date
|
22/09/21
|
28/03/22
|
14/03/23
|
25/03/24
|
-
|
-
|
-
|
Last Close Price
0.8787
USD Average target price
3.833
USD Spread / Average Target +336.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.68% | 43.75M | | +73.09% | 12.37B | | -18.39% | 7.96B | | +14.33% | 7.09B | | +4.95% | 5.83B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4B | | -35.92% | 2.41B | | +1.98% | 2B |
Medical Equipment
|